Literature DB >> 8020689

Mosaic regulation of lactase in human adult-type hypolactasia.

L Maiuri1, M Rossi, V Raia, V Garipoli, L A Hughes, D Swallow, O Norén, H Sjöström, S Auricchio.   

Abstract

BACKGROUND/AIMS: We have previously shown that in the proximal-jejunum of hypolactasic humans, just a few villus enterocytes express lactase protein and activity. In the present study, we compared the distribution of lactase messenger RNA (mRNA), protein, and activity in villus enterocytes in tissues obtained from subjects with persistent high lactase activity and those with hypolactasia.
METHODS: Immunohistochemical and enzymohistochemical staining was performed on closely adjacent sections of human proximal jejunum from 5 individuals with persistent high lactase activity and 32 with hypolactasia. In all the persistent and in 9 hypolactasic samples, in situ hybridization was also performed using a digoxygenin-labeled RNA probe.
RESULTS: In persistent tissues, lactase mRNA, protein, and activity were present in all villus enterocytes. In hypolactasic tissues, lactase mRNA was detected only in some villus enterocytes; some of them also expressed protein and activity, whereas others did not. In 8 of these hypolactasic samples, a variable number of villus enterocytes with lactase mRNA and protein did not express lactase activity.
CONCLUSIONS: Various types of enterocytes are present even on a single villus from individuals with adult-type hypolactasia. These results show that different mechanisms control lactase expression in enterocytes on the same villus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020689     DOI: 10.1016/0016-5085(94)90060-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Modelling molecular mechanisms controlling sequential gene expression in differentiating mammalian enterocytes.

Authors:  D Brown; M W Smith; A J Collins
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

2.  Lactose digestion and the evolutionary genetics of lactase persistence.

Authors:  Catherine J E Ingram; Charlotte A Mulcare; Yuval Itan; Mark G Thomas; Dallas M Swallow
Journal:  Hum Genet       Date:  2008-11-26       Impact factor: 4.132

3.  Regulation of lactase-phlorizin hydrolase gene expression by the caudal-related homoeodomain protein Cdx-2.

Authors:  J T Troelsen; C Mitchelmore; N Spodsberg; A M Jensen; O Norén; H Sjöström
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

4.  Studies on the expression of intestinal lactase in different individuals.

Authors:  C B Harvey; Y Wang; L A Hughes; D M Swallow; W P Thurrell; V R Sams; R Barton; S Lanzon-Miller; M Sarner
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

5.  Functional diversity and interactions between the repeat domains of rat intestinal lactase.

Authors:  B Jost; I Duluc; M Richardson; R Lathe; J N Freund
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

6.  Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes.

Authors:  S Guilmeau; I Niot; J P Laigneau; H Devaud; V Petit; N Brousse; R Bouvier; L Ferkdadji; C Besmond; L P Aggerbeck; A Bado; M E Samson-Bouma
Journal:  Histochem Cell Biol       Date:  2007-06-29       Impact factor: 4.304

7.  FAS engagement drives apoptosis of enterocytes of coeliac patients.

Authors:  L Maiuri; C Ciacci; V Raia; L Vacca; I Ricciardelli; F Raimondi; S Auricchio; S Quaratino; M Londei
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease).

Authors:  Amandine Georges; Jessica Bonneau; Dominique Bonnefont-Rousselot; Jacqueline Champigneulle; Jean P Rabès; Marianne Abifadel; Thomas Aparicio; Jean C Guenedet; Eric Bruckert; Catherine Boileau; Alain Morali; Mathilde Varret; Lawrence P Aggerbeck; Marie E Samson-Bouma
Journal:  Orphanet J Rare Dis       Date:  2011-01-14       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.